Financials (USD)
Sales 2024 * | 27.82M | Sales 2025 * | 90.05M | Capitalization | 245M |
---|---|---|---|---|---|
Net income 2024 * | -66M | Net income 2025 * | -21M | EV / Sales 2024 * | 8.98 x |
Net Debt 2024 * | 5M | Net Debt 2025 * | 17.3M | EV / Sales 2025 * | 2.91 x |
P/E ratio 2024 * |
-3.86
x | P/E ratio 2025 * |
-12.6
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.29% |
Latest transcript on KemPharm, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Christal Mickle
FOU | Founder | 45 | 06-10-29 |
Neil McFarlane
CEO | Chief Executive Officer | 51 | 23-10-09 |
R. Clifton
DFI | Director of Finance/CFO | 51 | 15-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wendy Dixon
BRD | Director/Board Member | 68 | 23-04-24 |
Tamara Favorito
CHM | Chairman | 65 | 21-08-17 |
Douglas Calder
BRD | Director/Board Member | 56 | 23-04-24 |
1st Jan change | Capi. | |
---|---|---|
+7.04% | 73.13B | |
+31.10% | 10.38B | |
+37.94% | 5.16B | |
-17.33% | 4.73B | |
+21.49% | 3.81B | |
+24.92% | 2.26B | |
-36.84% | 1.88B | |
-43.31% | 1.77B | |
-0.50% | 1.64B |